OligoG CF-5/20
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
AlgiPharma AS
Overview
OligoG CF-5/20 is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
OligoG CF-5/20 clinical trials
Explore related
Medical disclaimer. This page summarizes research about OligoG CF-5/20 for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.